Emerade epinephrine auto-injectors are being recalled because the devices could fail.
Health Canada says the 0.3 and 0.5 milligram injectors could malfunction when people suffering a serious allergic reaction try to use them.
That means they might not get the epinephrine they need to stop potentially deadly anaphylaxis.
Get weekly health news
The recalled lots of Emerade, produced by Quebec-based Bausch Health, were distributed in Canada between April 2022 and May 2023.
Health Canada is urging people to take their Emerade auto-injectors to their pharmacies as soon as possible to get a replacement.
They should talk to the pharmacist to make sure they know how to use the replacement device before leaving the pharmacy, the health agency says.
- PHAC finds no evidence of mystery brain disease in New Brunswick, says patients still need answers
- Beer recall hits 2 more Canadian products, bringing total to 31
- Alberta expanding use of AI tech that speeds up MRIs after successful pilot
- Stopping GLP-1 drugs could increase heart attack risk for some, study says
-
![]()
Health Matters: Pfizer to halt sales of certain hormone therapy -
![]()
CFL Fans Fight Cancer celebrates 20 years of making a difference and set record $100,000 fundraising goal -
![]()
Health-care workers dealing with more violent incidents -
![]()
The Quebec Health Institute signals early flu season as hospital ER room capacity surges
Health Canada says if someone has a serious allergic reaction before they can get a new device, they should still use the old one and then seek emergency medical attention.
Anyone with questions about the recall can contact Bausch Health, Canada Inc. by calling 1-800-361-4261.
Comments
Want to discuss? Please read our Commenting Policy first.